FGAs Flashcards
Lowest potency FGAs
thioridazine and chlorpromazine
Highest potency FGAs
fluphenazine and haloperidol
Lowest potency FGAs and the relationship with EPS and ACH risks
Lower potency FGAs have a higher ACH risk but a low EPS risk
Highest potency FGAs and the relationship with EPS and ACH
Highest potency FGAs have a high EPS risk but low ACH risk
Chlorpromazine indications
Schizo, acute psychosis
Thioridazine indication
Schizophrenia
Loxapine indications
Schizophrenia, BPD
Molindone indication
Schizo
Perphenazine indication
Schizo
Trifluoperazine indications
Schizo, anxiety
Thiothixene indication
Schizo
Fluphenazine indication
Schizo
Haloperidol indications
Schizo, Tourette’s, acute psychosis, problematic/hyperactive behavior
FGAs most implicated in sedation
chlorpromazine, thioridazine
FGAs most implicated in EPS
chlorpromazine, fluphenazine, haloperidol, perphenazine, thioridazine, thiothixene
FGAs most implicated in ACH
chlorpromazine, thioridazine
FGA most implicated in weight gain
chlorpromazine
FGAs most implicated in prolactin
chlorpromazine, fluphenazine, haloperidol, perphenazine, thioridazine, thiothixene
FGAs most implicated in CV side effects
haloperidol, chlorpromazine
FGAs that are available as LAIs
Fluphenazine decanoate, haloperidol decanoate
FGAs that are available as short-acting/acute agents
chlorpromazine, fluphenazine, haloperidol